Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma have?
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma has 951 citations in the OpenAlex counts ScholarIQ stores.
When was Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma published?
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma has 2019 year in the ScholarIQ index.
What is the open-access status of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma?
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma has bronze oa status in the ScholarIQ index.
What is the DOI of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma?
The DOI for Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma is on the source record.
What is the PMID of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma?
The PMID for Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma is on the source record.
What is the OpenAlex record for Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma?
The OpenAlex for Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma is on the source record.